Herbas VPB

Print
EN | LT
LT - DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
EN - DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/436
A61K 9/127
A61K 31/282
A61K 31/4745
A61K 31/475
A61K 31/513
A61K 31/519
A61P 35/04
European patent
(11) Number of the document 3337478
(13) Kind of document T
(96) European patent application number 16758337.6
Date of filing the European patent application 2016-08-19
(97) Date of publication of the European application 2018-06-27
(45) Date of publication and mention of the grant of the patent 2020-08-12
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2016/047727
Date 2016-08-19
PCT application publication
(87) Number WO 2017/034957
Date 2017-03-02
Priority applications
(30) Number Date Country code
201562208209 P 2015-08-21 US
201562216736 P 2015-09-10 US
201562273244 P 2015-12-30 US
201662281473 P 2016-01-21 US
201662302341 P 2016-03-02 US
201662323245 P 2016-04-15 US
201662343313 P 2016-05-31 US
Inventors
(72)
BLANCHETTE, Sarah, F., US
FITZGERALD, Jonathan, Basil, US
GADDY, Daniel, F., US
HENDRIKS, Bart, S., US
KALRA, Ashish, US
LEE, Helen, US
BAYEVER, Eliel, US
Grantee
(73) Ipsen Biopharm Ltd., Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, GB
Title
(54) DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
  DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
Last update date 2021-04-30